ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

University of Turin at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

University of Turin takes part in 11 sessions at ESMO 2026 in Madrid. Its work spans lung cancer, blood cancers, sarcoma, and molecular oncology. Specific studies explore predictors of treatment response in brain tumours and a biomarker for a drug combination in soft-tissue sarcoma.

OrganizationESMO 2026 Attendance
University & institute
Public university in Turin, Italy, with a school of medicine and a molecular biotechnology research centre.
Poster
Fri Oct 23
13:00–15:00
Teneurin 4: A novel driver of tumor progression and TME remodeling in TNBC
ePoster session 23
Breast cancer
Chair
Sat Oct 24
08:30–10:00
Proffered Paper: Haematological malignancies
with Institute of Oncology Research (IOR)
Haematological malignancies
Abstract
Sat Oct 24
09:00–09:10
Invited Discussant 1454O, 1455O and 1456O
Proffered Paper: Haematological malignancies
Haematological malignancies
Chair
Sat Oct 24
12:00–12:50
ESMO-EACR: What oncologists should know about molecular oncology
with Gustave Roussy, VIB
Biomarkers & precision oncology
Poster
Sat Oct 24
12:00–12:45
Talk
Sat Oct 24
12:00–12:15
RAS biology
ESMO-EACR: What oncologists should know about molecular oncology
Biomarkers & precision oncology
Satellite
Sat Oct 24
18:30–18:45
At a pivotal time: Where we stand today
PharmaMar - More time for patients: Reframing the course of ES-SCLC
Lung & thoracic cancers
Talk
Sun Oct 25
08:50–09:10
Novel approaches challenging the role of transplantation in the treatment of front-line myeloma
Changing paradigms in lymphomas and myeloma
Haematological malignancies
Satellite
Sun Oct 25
13:00–13:05
Welcome and Introductions
BeOne Medicines - Data, Debate, and New Directions in the NSCLC Continuum:​From Early-Stage Immunotherapy to New Modalities in Advanced Disease · with Hospital Universitario Puerta de Hierro Majadahonda
Lung & thoracic cancers
Satellite
Sun Oct 25
13:20–14:05
Neoadjuvant vs Perioperative Immunotherapy: An Expert Clinical Debate
BeOne Medicines - Data, Debate, and New Directions in the NSCLC Continuum:​From Early-Stage Immunotherapy to New Modalities in Advanced Disease · with University Hospital Cologne, Trinity St James's Cancer Institute, Hospital Universitario Puerta de Hierro Majadahonda +1 more
Lung & thoracic cancers
Satellite
Sun Oct 25
14:25–14:30
Close
BeOne Medicines - Data, Debate, and New Directions in the NSCLC Continuum:​From Early-Stage Immunotherapy to New Modalities in Advanced Disease · with Hospital Universitario Puerta de Hierro Majadahonda
Lung & thoracic cancers
Chair
Mon Oct 26
08:30–10:00
Navigating cellular aging: Optimising cancer therapy in the aging population
with Institute for Research in Biomedicine (IRB Barcelona)
Talk
Mon Oct 26
08:55–09:20
Placental-like reprogramming in early and late onset colorectal cancers
Navigating cellular aging: Optimising cancer therapy in the aging population

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at University of Turin

Tell us what you sell and we’ll find the people at University of Turin most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction